Tamar Thompson - Oct 7, 2024 Form 4 Insider Report for Avidity Biosciences, Inc. (RNA)

Role
Director
Signature
/s/ John B. Moriarty, Jr., J.D., Attorney-in-Fact
Stock symbol
RNA
Transactions as of
Oct 7, 2024
Transactions value $
-$520,359
Form type
4
Date filed
10/9/2024, 05:23 PM
Previous filing
Jun 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNA Common Stock Options Exercise $829K +30K $27.63 30K Oct 7, 2024 Direct
transaction RNA Common Stock Sale -$1.35M -30K -100% $44.98 0 Oct 7, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNA Stock Option (Right to Buy) Options Exercise $0 -30K -100% $0.00 0 Oct 7, 2024 Common Stock 30K $27.63 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.20 to $45.57. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The option was granted on January 11, 2021 and fully vested prior to the date of transactions described in this form.